CatalystAlert

Search CatalystAlert

Search for companies, drugs, and catalysts

Search CatalystAlert

Search for companies, drugs, and catalysts

yahoo_finance
Original article

OnKure Therapeutics Spotlights Allosteric PI3Kα Drugs as 2027 IND Targets Near

Trial StartPositive
AI Analysis

Summary

OnKure Therapeutics is advancing allosteric PI3Kα inhibitor drugs with IND application targets anticipated in 2027.

Importance:3/10
Sentiment:
0.40
allosteric_pi3k_alphaind_applicationpipeline_development
Related Companies

Read the original article

Published by yahoo_finance on July 15, 2026 5:02 PM

Read Original